img

Global Haemophilia Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Haemophilia Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Haemophilia is a mostly inherited genetic disorder that impairs the body's ability to make blood clots, a process needed to stop bleeding.
Haemophilia Treatment report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Haemophilia Treatment market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Pharmaceutical Companies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Haemophilia Treatment industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Haemophilia Treatment key manufacturers include Bayer, Novo Nordisk, Pfizer, Roche, Aptevo Therapeutics, Catalyst BioSciences, Dimension Therapeutics, Takeda and CSL Behring, etc. Bayer, Novo Nordisk, Pfizer are top 3 players and held % sales share in total in 2022.
Haemophilia Treatment can be divided into Haemophilia A and Haemophilia B, etc. Haemophilia A is the mainstream product in the market, accounting for % sales share globally in 2022.
Haemophilia Treatment is widely used in various fields, such as Hospital, Pharmaceutical Companies and Other,, etc. Hospital provides greatest supports to the Haemophilia Treatment industry development. In 2022, global % sales of Haemophilia Treatment went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Haemophilia Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bayer
Novo Nordisk
Pfizer
Roche
Aptevo Therapeutics
Catalyst BioSciences
Dimension Therapeutics
Takeda
CSL Behring
Alnylam Pharmaceuticals
Segment by Type
Haemophilia A
Haemophilia B

Segment by Application


Hospital
Pharmaceutical Companies
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Haemophilia Treatment market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Haemophilia Treatment, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Haemophilia Treatment industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Haemophilia Treatment in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Haemophilia Treatment introduction, etc. Haemophilia Treatment Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Haemophilia Treatment market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Haemophilia Treatment Market Overview
1.1 Haemophilia Treatment Product Overview
1.2 Haemophilia Treatment Market Segment by Type
1.2.1 Haemophilia A
1.2.2 Haemophilia B
1.3 Global Haemophilia Treatment Market Size by Type
1.3.1 Global Haemophilia Treatment Market Size Overview by Type (2018-2034)
1.3.2 Global Haemophilia Treatment Historic Market Size Review by Type (2018-2024)
1.3.3 Global Haemophilia Treatment Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Haemophilia Treatment Sales Breakdown by Type (2018-2024)
1.4.2 Europe Haemophilia Treatment Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Haemophilia Treatment Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Haemophilia Treatment Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Haemophilia Treatment Sales Breakdown by Type (2018-2024)
2 Global Haemophilia Treatment Market Competition by Company
2.1 Global Top Players by Haemophilia Treatment Sales (2018-2024)
2.2 Global Top Players by Haemophilia Treatment Revenue (2018-2024)
2.3 Global Top Players by Haemophilia Treatment Price (2018-2024)
2.4 Global Top Manufacturers Haemophilia Treatment Manufacturing Base Distribution, Sales Area, Product Type
2.5 Haemophilia Treatment Market Competitive Situation and Trends
2.5.1 Haemophilia Treatment Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Haemophilia Treatment Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Haemophilia Treatment as of 2022)
2.7 Date of Key Manufacturers Enter into Haemophilia Treatment Market
2.8 Key Manufacturers Haemophilia Treatment Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Haemophilia Treatment Status and Outlook by Region
3.1 Global Haemophilia Treatment Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Haemophilia Treatment Historic Market Size by Region
3.2.1 Global Haemophilia Treatment Sales in Volume by Region (2018-2024)
3.2.2 Global Haemophilia Treatment Sales in Value by Region (2018-2024)
3.2.3 Global Haemophilia Treatment Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Haemophilia Treatment Forecasted Market Size by Region
3.3.1 Global Haemophilia Treatment Sales in Volume by Region (2024-2034)
3.3.2 Global Haemophilia Treatment Sales in Value by Region (2024-2034)
3.3.3 Global Haemophilia Treatment Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Haemophilia Treatment by Application
4.1 Haemophilia Treatment Market Segment by Application
4.1.1 Hospital
4.1.2 Pharmaceutical Companies
4.1.3 Other
4.2 Global Haemophilia Treatment Market Size by Application
4.2.1 Global Haemophilia Treatment Market Size Overview by Application (2018-2034)
4.2.2 Global Haemophilia Treatment Historic Market Size Review by Application (2018-2024)
4.2.3 Global Haemophilia Treatment Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Haemophilia Treatment Sales Breakdown by Application (2018-2024)
4.3.2 Europe Haemophilia Treatment Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Haemophilia Treatment Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Haemophilia Treatment Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Haemophilia Treatment Sales Breakdown by Application (2018-2024)
5 North America Haemophilia Treatment by Country
5.1 North America Haemophilia Treatment Historic Market Size by Country
5.1.1 North America Haemophilia Treatment Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Haemophilia Treatment Sales in Volume by Country (2018-2024)
5.1.3 North America Haemophilia Treatment Sales in Value by Country (2018-2024)
5.2 North America Haemophilia Treatment Forecasted Market Size by Country
5.2.1 North America Haemophilia Treatment Sales in Volume by Country (2024-2034)
5.2.2 North America Haemophilia Treatment Sales in Value by Country (2024-2034)
6 Europe Haemophilia Treatment by Country
6.1 Europe Haemophilia Treatment Historic Market Size by Country
6.1.1 Europe Haemophilia Treatment Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Haemophilia Treatment Sales in Volume by Country (2018-2024)
6.1.3 Europe Haemophilia Treatment Sales in Value by Country (2018-2024)
6.2 Europe Haemophilia Treatment Forecasted Market Size by Country
6.2.1 Europe Haemophilia Treatment Sales in Volume by Country (2024-2034)
6.2.2 Europe Haemophilia Treatment Sales in Value by Country (2024-2034)
7 Asia-Pacific Haemophilia Treatment by Region
7.1 Asia-Pacific Haemophilia Treatment Historic Market Size by Region
7.1.1 Asia-Pacific Haemophilia Treatment Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Haemophilia Treatment Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Haemophilia Treatment Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Haemophilia Treatment Forecasted Market Size by Region
7.2.1 Asia-Pacific Haemophilia Treatment Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Haemophilia Treatment Sales in Value by Region (2024-2034)
8 Latin America Haemophilia Treatment by Country
8.1 Latin America Haemophilia Treatment Historic Market Size by Country
8.1.1 Latin America Haemophilia Treatment Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Haemophilia Treatment Sales in Volume by Country (2018-2024)
8.1.3 Latin America Haemophilia Treatment Sales in Value by Country (2018-2024)
8.2 Latin America Haemophilia Treatment Forecasted Market Size by Country
8.2.1 Latin America Haemophilia Treatment Sales in Volume by Country (2024-2034)
8.2.2 Latin America Haemophilia Treatment Sales in Value by Country (2024-2034)
9 Middle East and Africa Haemophilia Treatment by Country
9.1 Middle East and Africa Haemophilia Treatment Historic Market Size by Country
9.1.1 Middle East and Africa Haemophilia Treatment Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Haemophilia Treatment Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Haemophilia Treatment Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Haemophilia Treatment Forecasted Market Size by Country
9.2.1 Middle East and Africa Haemophilia Treatment Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Haemophilia Treatment Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Bayer
10.1.1 Bayer Company Information
10.1.2 Bayer Introduction and Business Overview
10.1.3 Bayer Haemophilia Treatment Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Bayer Haemophilia Treatment Products Offered
10.1.5 Bayer Recent Development
10.2 Novo Nordisk
10.2.1 Novo Nordisk Company Information
10.2.2 Novo Nordisk Introduction and Business Overview
10.2.3 Novo Nordisk Haemophilia Treatment Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Novo Nordisk Haemophilia Treatment Products Offered
10.2.5 Novo Nordisk Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Haemophilia Treatment Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Pfizer Haemophilia Treatment Products Offered
10.3.5 Pfizer Recent Development
10.4 Roche
10.4.1 Roche Company Information
10.4.2 Roche Introduction and Business Overview
10.4.3 Roche Haemophilia Treatment Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Roche Haemophilia Treatment Products Offered
10.4.5 Roche Recent Development
10.5 Aptevo Therapeutics
10.5.1 Aptevo Therapeutics Company Information
10.5.2 Aptevo Therapeutics Introduction and Business Overview
10.5.3 Aptevo Therapeutics Haemophilia Treatment Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Aptevo Therapeutics Haemophilia Treatment Products Offered
10.5.5 Aptevo Therapeutics Recent Development
10.6 Catalyst BioSciences
10.6.1 Catalyst BioSciences Company Information
10.6.2 Catalyst BioSciences Introduction and Business Overview
10.6.3 Catalyst BioSciences Haemophilia Treatment Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Catalyst BioSciences Haemophilia Treatment Products Offered
10.6.5 Catalyst BioSciences Recent Development
10.7 Dimension Therapeutics
10.7.1 Dimension Therapeutics Company Information
10.7.2 Dimension Therapeutics Introduction and Business Overview
10.7.3 Dimension Therapeutics Haemophilia Treatment Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Dimension Therapeutics Haemophilia Treatment Products Offered
10.7.5 Dimension Therapeutics Recent Development
10.8 Takeda
10.8.1 Takeda Company Information
10.8.2 Takeda Introduction and Business Overview
10.8.3 Takeda Haemophilia Treatment Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Takeda Haemophilia Treatment Products Offered
10.8.5 Takeda Recent Development
10.9 CSL Behring
10.9.1 CSL Behring Company Information
10.9.2 CSL Behring Introduction and Business Overview
10.9.3 CSL Behring Haemophilia Treatment Sales, Revenue and Gross Margin (2018-2024)
10.9.4 CSL Behring Haemophilia Treatment Products Offered
10.9.5 CSL Behring Recent Development
10.10 Alnylam Pharmaceuticals
10.10.1 Alnylam Pharmaceuticals Company Information
10.10.2 Alnylam Pharmaceuticals Introduction and Business Overview
10.10.3 Alnylam Pharmaceuticals Haemophilia Treatment Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Alnylam Pharmaceuticals Haemophilia Treatment Products Offered
10.10.5 Alnylam Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Haemophilia Treatment Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Haemophilia Treatment Industrial Chain Analysis
11.4 Haemophilia Treatment Market Dynamics
11.4.1 Haemophilia Treatment Industry Trends
11.4.2 Haemophilia Treatment Market Drivers
11.4.3 Haemophilia Treatment Market Challenges
11.4.4 Haemophilia Treatment Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Haemophilia Treatment Distributors
12.3 Haemophilia Treatment Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Haemophilia A
Table 2. Major Company of Haemophilia B
Table 3. Global Haemophilia Treatment Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Haemophilia Treatment Sales by Type (2018-2024) & (K Units)
Table 5. Global Haemophilia Treatment Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Haemophilia Treatment Sales by Type (2018-2024) & (US& Million)
Table 7. Global Haemophilia Treatment Market Share in Value by Type (2018-2024)
Table 8. Global Haemophilia Treatment Price by Type (2018-2024) & (USD/Unit)
Table 9. Global Haemophilia Treatment Sales by Type (2024-2034) & (K Units)
Table 10. Global Haemophilia Treatment Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Haemophilia Treatment Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Haemophilia Treatment Sales Market Share in Value by Type (2024-2034)
Table 13. Global Haemophilia Treatment Price by Type (2024-2034) & (USD/Unit)
Table 14. North America Haemophilia Treatment Sales by Type (2018-2024) & (K Units)
Table 15. North America Haemophilia Treatment Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Haemophilia Treatment Sales (K Units) by Type (2018-2024)
Table 17. Europe Haemophilia Treatment Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Haemophilia Treatment Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Haemophilia Treatment Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Haemophilia Treatment Sales (K Units) by Type (2018-2024)
Table 21. Latin America Haemophilia Treatment Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Haemophilia Treatment Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Haemophilia Treatment Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Haemophilia Treatment Sales by Company (2018-2024) & (K Units)
Table 25. Global Haemophilia Treatment Sales Share by Company (2018-2024)
Table 26. Global Haemophilia Treatment Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Haemophilia Treatment Revenue Share by Company (2018-2024)
Table 28. Global Market Haemophilia Treatment Price by Company (2018-2024) & (USD/Unit)
Table 29. Global Haemophilia Treatment Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Haemophilia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Haemophilia Treatment as of 2022)
Table 32. Date of Key Manufacturers Enter into Haemophilia Treatment Market
Table 33. Key Manufacturers Haemophilia Treatment Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Haemophilia Treatment Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Haemophilia Treatment Sales by Region (2018-2024) & (K Units)
Table 37. Global Haemophilia Treatment Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Haemophilia Treatment Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Haemophilia Treatment Sales Market Share in Value by Region (2018-2024)
Table 40. Global Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 41. Global Haemophilia Treatment Sales by Region (2024-2034) & (K Units)
Table 42. Global Haemophilia Treatment Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Haemophilia Treatment Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Haemophilia Treatment Sales Market Share in Value by Region (2024-2034)
Table 45. Global Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 46. Global Haemophilia Treatment Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Haemophilia Treatment Sales by Application (2018-2024) & (K Units)
Table 48. Global Haemophilia Treatment Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Haemophilia Treatment Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Haemophilia Treatment Sales Market Share in Value by Application (2018-2024)
Table 51. Global Haemophilia Treatment Price by Application (2018-2024) & (USD/Unit)
Table 52. Global Haemophilia Treatment Sales by Application (2024-2034) & (K Units)
Table 53. Global Haemophilia Treatment Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Haemophilia Treatment Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Haemophilia Treatment Sales Market Share in Value by Application (2024-2034)
Table 56. Global Haemophilia Treatment Price by Application (2024-2034) & (USD/Unit)
Table 57. North America Haemophilia Treatment Sales by Application (2018-2024) (K Units)
Table 58. North America Haemophilia Treatment Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Haemophilia Treatment Sales by Application (2018-2024) (K Units)
Table 60. Europe Haemophilia Treatment Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Haemophilia Treatment Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Haemophilia Treatment Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Haemophilia Treatment Sales by Application (2018-2024) (K Units)
Table 64. Latin America Haemophilia Treatment Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Haemophilia Treatment Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Haemophilia Treatment Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Haemophilia Treatment Sales by Country (2018-2024) & (K Units)
Table 68. North America Haemophilia Treatment Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Haemophilia Treatment Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Haemophilia Treatment Sales Market Share in Value by Country (2018-2024)
Table 71. North America Haemophilia Treatment Sales by Country (2024-2034) & (K Units)
Table 72. North America Haemophilia Treatment Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Haemophilia Treatment Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Haemophilia Treatment Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Haemophilia Treatment Sales by Country (2018-2024) & (K Units)
Table 76. Europe Haemophilia Treatment Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Haemophilia Treatment Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Haemophilia Treatment Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Haemophilia Treatment Sales by Country (2024-2034) & (K Units)
Table 80. Europe Haemophilia Treatment Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Haemophilia Treatment Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Haemophilia Treatment Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Haemophilia Treatment Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Haemophilia Treatment Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Haemophilia Treatment Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Haemophilia Treatment Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Haemophilia Treatment Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Haemophilia Treatment Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Haemophilia Treatment Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Haemophilia Treatment Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Haemophilia Treatment Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Haemophilia Treatment Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Haemophilia Treatment Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Haemophilia Treatment Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Haemophilia Treatment Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Haemophilia Treatment Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Haemophilia Treatment Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Haemophilia Treatment Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Haemophilia Treatment Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Haemophilia Treatment Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Haemophilia Treatment Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Haemophilia Treatment Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Haemophilia Treatment Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Haemophilia Treatment Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Haemophilia Treatment Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Haemophilia Treatment Sales Market Share in Value by Country (2024-2034)
Table 107. Bayer Company Information
Table 108. Bayer Introduction and Business Overview
Table 109. Bayer Haemophilia Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Bayer Haemophilia Treatment Product
Table 111. Bayer Recent Development
Table 112. Novo Nordisk Company Information
Table 113. Novo Nordisk Introduction and Business Overview
Table 114. Novo Nordisk Haemophilia Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Novo Nordisk Haemophilia Treatment Product
Table 116. Novo Nordisk Recent Development
Table 117. Pfizer Company Information
Table 118. Pfizer Introduction and Business Overview
Table 119. Pfizer Haemophilia Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Pfizer Haemophilia Treatment Product
Table 121. Pfizer Recent Development
Table 122. Roche Company Information
Table 123. Roche Introduction and Business Overview
Table 124. Roche Haemophilia Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Roche Haemophilia Treatment Product
Table 126. Roche Recent Development
Table 127. Aptevo Therapeutics Company Information
Table 128. Aptevo Therapeutics Introduction and Business Overview
Table 129. Aptevo Therapeutics Haemophilia Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Aptevo Therapeutics Haemophilia Treatment Product
Table 131. Aptevo Therapeutics Recent Development
Table 132. Catalyst BioSciences Company Information
Table 133. Catalyst BioSciences Introduction and Business Overview
Table 134. Catalyst BioSciences Haemophilia Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Catalyst BioSciences Haemophilia Treatment Product
Table 136. Catalyst BioSciences Recent Development
Table 137. Dimension Therapeutics Company Information
Table 138. Dimension Therapeutics Introduction and Business Overview
Table 139. Dimension Therapeutics Haemophilia Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Dimension Therapeutics Haemophilia Treatment Product
Table 141. Dimension Therapeutics Recent Development
Table 142. Takeda Company Information
Table 143. Takeda Introduction and Business Overview
Table 144. Takeda Haemophilia Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Takeda Haemophilia Treatment Product
Table 146. Takeda Recent Development
Table 147. CSL Behring Company Information
Table 148. CSL Behring Introduction and Business Overview
Table 149. CSL Behring Haemophilia Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. CSL Behring Haemophilia Treatment Product
Table 151. CSL Behring Recent Development
Table 152. Alnylam Pharmaceuticals Company Information
Table 153. Alnylam Pharmaceuticals Introduction and Business Overview
Table 154. Alnylam Pharmaceuticals Haemophilia Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 155. Alnylam Pharmaceuticals Haemophilia Treatment Product
Table 156. Alnylam Pharmaceuticals Recent Development
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Haemophilia Treatment Market Trends
Table 160. Haemophilia Treatment Market Drivers
Table 161. Haemophilia Treatment Market Challenges
Table 162. Haemophilia Treatment Market Restraints
Table 163. Haemophilia Treatment Distributors List
Table 164. Haemophilia Treatment Downstream Customers
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Haemophilia Treatment Product Picture
Figure 2. Global Haemophilia Treatment Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Haemophilia Treatment Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Haemophilia Treatment Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Haemophilia A
Figure 6. Global Haemophilia A Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Haemophilia B
Figure 8. Global Haemophilia B Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Global Haemophilia Treatment Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Haemophilia Treatment Sales Market Share by Type in 2022 & 2034
Figure 11. North America Haemophilia Treatment Sales Market Share in Volume by Type in 2022
Figure 12. North America Haemophilia Treatment Sales Market Share in Value by Type in 2022
Figure 13. Europe Haemophilia Treatment Sales Market Share in Volume by Type in 2022
Figure 14. Europe Haemophilia Treatment Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Haemophilia Treatment Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Haemophilia Treatment Sales Market Share in Value by Type in 2022
Figure 17. Latin America Haemophilia Treatment Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Haemophilia Treatment Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Haemophilia Treatment Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Haemophilia Treatment Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Haemophilia Treatment Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Haemophilia Treatment Revenue in 2022
Figure 23. Haemophilia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2018-2034) & (K Units)
Figure 26. Product Picture of Pharmaceutical Companies
Figure 27. Global Pharmaceutical Companies Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Other
Figure 29. Global Other Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Global Haemophilia Treatment Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Haemophilia Treatment Sales Market Share by Application in 2022 & 2034
Figure 32. North America Haemophilia Treatment Sales Market Share in Volume by Application in 2022
Figure 33. North America Haemophilia Treatment Sales Market Share in Value by Application in 2022
Figure 34. Europe Haemophilia Treatment Sales Market Share in Volume by Application in 2022
Figure 35. Europe Haemophilia Treatment Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Haemophilia Treatment Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Haemophilia Treatment Sales Market Share in Value by Application in 2022
Figure 38. Latin America Haemophilia Treatment Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Haemophilia Treatment Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Haemophilia Treatment Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Haemophilia Treatment Manufacturing Cost Structure
Figure 43. Haemophilia Treatment Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries